S.C. Ropharma Ratios and Metrics

Market cap in millions RON. Fiscal year is January - December.

Millions RON. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May '26 May 15, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	102	82	102	96	106	117
Market Cap Growth	35.14%	-19.50%	6.95%	-9.83%	-9.57%	-16.60%
Enterprise Value	252	231	225	217	236	257
Last Close Price	0.20	0.16	0.20	0.19	0.21	0.23
PE Ratio	29.42	-	13.25	10.38	9.88	17.36
Forward PE	-	18.17	18.17	18.17	18.17	18.17
PS Ratio	0.07	0.06	0.09	0.10	0.12	0.14
PB Ratio	0.39	0.32	0.41	0.41	0.48	0.58
P/TBV Ratio	0.57	0.44	0.55	0.53	0.64	0.77
P/FCF Ratio	2.68	2.55	3.80	8.05	4.93	-
P/OCF Ratio	1.95	1.91	2.53	3.19	2.74	-
EV/Sales Ratio	0.17	0.17	0.20	0.22	0.27	0.32
EV/EBITDA Ratio	4.33	5.60	6.23	8.96	7.52	10.18
EV/EBIT Ratio	9.17	9.45	11.26	23.41	13.78	24.32
EV/FCF Ratio	6.63	7.14	8.38	18.24	10.95	-
Debt / Equity Ratio	0.70	0.63	0.65	0.64	0.62	0.72
Debt / EBITDA Ratio	3.16	3.06	3.52	4.49	3.40	4.39
Debt / FCF Ratio	4.83	5.03	6.10	12.49	6.35	-
Net Debt / Equity Ratio	0.52	0.55	0.59	0.57	0.57	0.65
Net Debt / EBITDA Ratio	2.97	3.46	4.08	5.50	4.02	5.21
Net Debt / FCF Ratio	3.56	4.41	5.49	11.19	5.86	-6.35
Asset Turnover	1.51	1.51	1.42	1.39	1.35	1.22
Inventory Turnover	5.10	5.19	5.25	5.44	5.61	5.18
Quick Ratio	0.64	0.62	0.63	0.64	0.65	0.65
Current Ratio	1.06	1.05	1.01	1.01	1.01	1.00
Return on Equity (ROE)	3.56%	2.10%	4.81%	3.31%	5.49%	2.38%
Return on Assets (ROA)	1.77%	1.74%	1.59%	0.80%	1.62%	1.00%
Return on Invested Capital (ROIC)	2.61%	1.52%	4.46%	1.89%	4.31%	2.25%
Return on Capital Employed (ROCE)	7.00%	6.50%	5.50%	2.80%	5.60%	3.60%
Earnings Yield	3.38%	-2.10%	7.55%	9.64%	10.12%	5.76%
FCF Yield	37.27%	39.23%	26.30%	12.42%	20.31%	-17.64%
Buyback Yield / Dilution	0.89%	-	-	-	-0.30%	0.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.